Triplet Therapeutics develops and commercializes ribonucleic acid targeted therapeutics for the treatment of Huntington's disease.
Business Model:
Revenue: $3.5M
Employees: 51-200
Address: One Kendall Square 1400W
City: Cambridge
State: MA
Zip: 02139
Country: US
Triplet Therapeutics develops and commercializes ribonucleic acid targeted therapeutics for the treatment of Huntington's disease.
Contact Phone:
+17812997830
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2019 | Seed Round | 1 | $10M |
Atlas Venture Atlas Venture |
12/2019 | Series A | 6 | $49M |
Alexandria Venture Atlas Venture Invus MPM Capital Partners Innovation Fund Pfizer Venture Investments Alexandria Venture Atlas Venture Invus MPM Capital Partners Innovation Fund Pfizer Venture Investments |
6/2018 | Seed | $10M |
Atlas Venture |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|